← Back to Clinical Trials
Recruiting NCT06718374

NCT06718374 Chest Pain Symptoms Differences Between Diabetic Patients and Non

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06718374
Status Recruiting
Phase
Sponsor Assiut University
Condition Chest Pain
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-01-10
Primary Completion 2025-10

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-01-10 with a primary completion date of 2025-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cardiovascular disease is the most severe cause of death among all non-infectious diseases and accountable for 17.5 million deaths in the world. Heart mortality in patients with DM is frequently associated with prevalence silent ischemia, which is triggered by autonomic neuropathy, thereby decreasing the chest pain felt by them

Eligibility Criteria

Inclusion Criteria: i) Patients diagnosed with STEMI and NSTEMI ii) Both genders iii) above the age of 30 years iv) Patients with acute myocardial infarction with or without chest pain (angina) for 24 hours v) patients who are hemodynamically stable vi) patients without acute decompensated heart failure (ADHF) vii) patients without malignant arrhythmias viii) patients without in Acute Lung Oedem (ALO) condition ix) patients not using ventilator x) patient willing to and become respondents. Exclusion Criteria: i) Patients with several complications, thereby making it impossible to interview them ii) patients who have never undergone CABG surgery iii) patients who refuse to be respondents

Contact & Investigator

Central Contact

Antonios S Ishak, Resident

✉ tonysamir993@gmail.com

📞 1226366806

Principal Investigator

Essam El-dien M Abdullah, MD

STUDY DIRECTOR

Assiut University

Frequently Asked Questions

Who can join the NCT06718374 clinical trial?

This trial is open to participants of all sexes, studying Chest Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06718374 currently recruiting?

Yes, NCT06718374 is actively recruiting participants. Contact the research team at tonysamir993@gmail.com for enrollment information.

Where is the NCT06718374 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT06718374 clinical trial?

NCT06718374 is sponsored by Assiut University. The principal investigator is Essam El-dien M Abdullah, MD at Assiut University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology